 Home > Medical News > Latest Medical News > Decei Pharma and Bristol-Myers Squibb will jointly promote the clinical development of ATG-017 and Odivo

Decei Pharma and Bristol-Myers Squibb will jointly promote the clinical development of ATG-017 and Odivo

 Last Update: 2022-01-11
 Source: Internet
 Author: User

Tags

automated data collection

host cell protein

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

ATG-017 is an oral small molecule ERK1/2 inhibitor; Odivo® is a PD-1 checkpoint inhibitor.

Shanghai and Hong Kong, December 13, 2021/PRNewswire/ - Deqi Pharmaceutical Co.

Dr.

ATG-017 is a selective oral inhibitor that acts on extracellular signal-regulated kinase 1 and 2 (ERK1/2)

Dr.

ATG-017 is currently being evaluated in an open, multicenter, phase 1/2 dose exploratory trial called ERASER for the treatment of patients with mutations in the RAS-MAPK pathway

According to the agreement, Deqi Pharmaceuticals will be responsible for the development of the clinical trial and provide financial support

About ATG-017

ATG-017 is a potent and selective small molecule inhibitor that acts on extracellular signal-regulated kinase 1 and 2 (ERK1/2)

Deqi Pharmaceuticals announced relevant preclinical research data at the 2021 Society of Tumor Immunotherapy (SITC) Annual Meeting held recently

About Deqi Pharmaceutical

Deqi Pharmaceutical Co.

Forward-looking statements

The forward-looking statements made in this article only relate to events or information as of the date when the statement is made in this article

Source: Deqi Pharmaceutical Co.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.